The authors present results from comparisons of insulin prices between the United States and 33 Organisation for Economic Co-operation and Development countries overall and for different categories of insulin using a price index approach. They present separate comparisons using U.S. manufacturer gross prices reflected at pharmacies and estimated manufacturer net prices after applying rebates paid by manufacturers.
No takes yet. Share an insight, caveat, or question.
Mulcahy et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: